SINGAPORE - Scientists here are developing an anti-cancer drug which, unlike its peers, can "home in" on the energy production centres of cancer cells and destroy them - leaving healthy cells and tissues untouched in the process.
Together with a counterpart from the Hebrew University of Jerusalem, the team of three researchers from the National University of Singapore (NUS) were looking into developing an anti-cancer drug with better treatment outcomes to serve as an alternative to cisplatin, a platinum-based drug which has been used since 1965.
Already a subscriber? Log in
Read the full story and more at $9.90/month
Get exclusive reports and insights with more than 500 subscriber-only articles every month
ST One Digital
$9.90/month
No contract
ST app access on 1 mobile device
Unlock these benefits
All subscriber-only content on ST app and straitstimes.com
Easy access any time via ST app on 1 mobile device
E-paper with 2-week archive so you won't miss out on content that matters to you
